New Page | Noumena

top of page

Original on Transparent.png

References (click on each to open the PubMed publication page) :

1. Orforglipron data from: Wharton S, et al. N Engl J Med. 2023 Sep 7;389(10):877-888. PMID: 37351564

2. GSBR-1290 data from: Structure Therapeutics Phase 2a data presentation on the 18th of December 2023

3. Danuglipron 200 mg data from: Saxena A.R. et al. Diabetes Obes Metab. 2023 Oct;25(10):2805-2814. PMID: 37311722

4. Semaglutide 50 mg data from: Knop FK et al. Lancet. 2023 Aug 26;402(10403):705-719. PMID: 37385278

5. Liraglutide 3 mg s.c. phase 2 data from: A. Astrup et al. Lancet. 2009 Nov 7;374(9701):1606-16. PMID: 19853906

6. Liraglutide 3 mg vs Semaglutide 2.4 mg phase 3 data from: D.M. Rubino et al. JAMA. 2022 Jan 11;327(2):138-150. PMID: 35015037

bottom of page